DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe. The acquisition brings together IMS Health’s comprehensive information and technology services with Forcea’s hospital-based technology solutions to drive more effective clinical and cost decisions. Forcea solutions will leverage IMS One, the company’s intelligent cloud-based platform that seamlessly provisions industry information and integrates IMS Health, client and third-party data for faster, more insightful decision making. Financial terms of the transaction were not disclosed.
With this acquisition, IMS Health further strengthens its leadership in business intelligence capabilities focused on enabling better care coordination and improved operating performance. Since 2006, Forcea has worked closely with hospitals, life sciences companies and other industry stakeholders in Europe to deliver strategic advisory services and analytics that include data warehousing implementation, benchmarking and mobile solutions. IMS Health’s global footprint and Forcea’s performance management applications will accelerate the delivery of mission-critical, customizable insights to improve outcomes and support the ongoing transformation of healthcare systems.
“For life sciences organizations and providers, the challenge today is to connect and coordinate insights that make vast amounts of information more actionable and healthcare systems more cost efficient – all while improving patient care,” said Alistair Grenfell, president, North Europe, IMS Health. “Forcea’s deep technical expertise and hospital-based business intelligence capabilities complement our extensive information assets and experience in helping clients better analyze data, visualize opportunities and drive measurable performance gains.”
As healthcare information becomes more connected locally, regionally and globally, IMS Health is empowering a growing set of clients worldwide to apply health informatics to improve patient outcomes and better manage the total cost of care.
“Advancing healthcare quality through technology innovation is a goal that we share with IMS Health, and we’re very excited to join that team,” said Frank Swaelens, co-founder and managing partner at Forcea. “There is a growing demand within the European Union for solutions that enable more efficient use of healthcare resources and establish performance benchmarks. Together, our teams are uniquely poised to support clients with meaningful, evidence-based analysis that is critical to more insightful healthcare.”
Additional information about Forcea is available at www.forcea.be.
This press release includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including statements we make regarding expected benefits from the Forcea acquisition. The words “believes,” “expects,” “may,” “will” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees that the future results, plans, intentions or expectations expressed or implied will be achieved. Matters subject to forward-looking statements involve known and unknown risks and uncertainties, including regulatory, competitive and other factors, which may cause actual financial or operating results or the timing of events to be materially different than those expressed or implied by forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to, our ability to successfully integrate Forcea, and the factors set forth in the “Risk Factors” section of our registration statement on Form S-1 on file with the SEC and any subsequent SEC filings. We disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release, and you should not rely on those statements as representing our views as of any date subsequent to the date of this press release.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. By applying sophisticated analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to help its clients run their operations more efficiently. Drawing on information from 100,000 suppliers, and on insights from more than 45 billion healthcare transactions processed annually, IMS Health’s approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.